U.S. Clinical Trial for COVID-19 Vaccine Starts at NYU Langone Health
May 06, 2020
May 06, 2020
NEW YORK, May 6 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release on May 5:
The first U.S. patients have been dosed in a clinical trial testing whether four experimental messenger RNA (mRNA) vaccine candidates can prevent infection with the virus that causes 2019 coronavirus disease (COVID-19).
Pfizer Inc. and BioNTech SE today announced the trial's start, with NYU Grossman School of Medicine and the . . .
The first U.S. patients have been dosed in a clinical trial testing whether four experimental messenger RNA (mRNA) vaccine candidates can prevent infection with the virus that causes 2019 coronavirus disease (COVID-19).
Pfizer Inc. and BioNTech SE today announced the trial's start, with NYU Grossman School of Medicine and the . . .